Management of COPD Patients Using Current Best Practice

Chronic Obstructive Pulmonary Disease (COPD) remains one of the most challenging chronic conditions to manage, with high morbidity, frequent exacerbations, and costly healthcare utilization. Patients often struggle with breathlessness during routine tasks, reduced independence, and recurrent hospital visits.

For providers, the management challenge is twofold: delivering day-to-day symptom control while preventing destabilizing exacerbations that drive readmissions, penalties, and rising costs. While medications and rehabilitation remain central, today’s best practice increasingly points toward a more comprehensive, connected approach—one that integrates Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) into routine COPD care.

---

Current Guidelines for COPD Management

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 guidelines provide a clear clinical framework for evidence-based COPD care. Recommendations include:

• Early detection through spirometry.

   

• Stepwise treatment escalation, from bronchodilator monotherapy to dual or triple therapy.

   

• Personalized treatment planning that accounts for exacerbation risk and comorbidities.

   

While these guidelines inform clinical decision-making, they also highlight a gap: consistent patient monitoring and engagement between office visits. This is where RPM and CCM become critical—operationalizing guideline-driven care in a way that reduces hospitalizations, improves adherence, and supports providers in meeting value-based care metrics.

---

The Role of Spirometry

Spirometry is the gold standard for COPD diagnosis and monitoring, but it offers only a snapshot in time. COPD patients often experience daily variability in symptoms that spirometry cannot capture.

RPM extends the provider’s reach. By monitoring oxygen saturation, heart rate, and even activity levels in near real time, RPM generates a continuous dataset. This allows clinicians to:

• Detect early deterioration before it becomes a full exacerbation.

   

• Intervene sooner, often avoiding an ED visit or hospital admission.

   

• Provide documented proof of proactive management for payer and compliance reporting.

   

For providers engaged in value-based contracts, these capabilities translate directly into reduced penalties, shared savings, and stronger performance scores.

---

Pharmacological Management of COPD

First-Line Therapies

Medications remain foundational, with three main categories:

• Bronchodilators to reduce bronchoconstriction.

   

• Inhaled corticosteroids (ICS) for frequent exacerbators.

   

• Combination inhalers to improve adherence and reduce complexity.

   

Personalized Treatment Plans

Not all patients respond uniformly. Providers must weigh:

• Symptom burden (CAT, mMRC).

   

• Exacerbation frequency and severity.

   

• Comorbidities like cardiovascular disease or diabetes.

   

Here, CCM adds measurable value. Monthly check-ins allow care teams to reinforce medication adherence, reconcile polypharmacy, and address lifestyle barriers. By preventing missed doses, uncontrolled comorbidities, and gaps in care, CCM reduces exacerbation risk while also generating consistent, billable revenue for practices.

Advances in Inhaler Technology

New digital inhalers add an additional layer of monitoring by tracking usage and providing reminders. Integrated into RPM platforms like TelliHealth’s, these insights allow providers to correlate inhaler adherence with real-time clinical data—closing the loop between prescription and actual outcomes.

---

Non-Pharmacological Management Strategies

Beyond medications, non-drug interventions remain critical.

Smoking Cessation

Cessation is still the most effective intervention in slowing COPD progression. CCM programs provide structured reinforcement through ongoing counseling, NRT support, and medication monitoring—keeping patients engaged long after the clinic visit.

Pulmonary Rehabilitation

Pulmonary rehab reduces dyspnea, improves quality of life, and decreases hospitalizations. Yet adherence remains a challenge. RPM platforms can complement rehab by tracking daily activity levels and providing accountability, ensuring patients stay on course and providers capture measurable progress.

Oxygen Therapy and Surgery

For advanced cases, long-term oxygen therapy improves survival. RPM makes it possible to track oxygen saturation remotely, helping clinicians identify patients who may need adjustments before they deteriorate to hospitalization.

---

Lifestyle and Self-Management Support

Self-management is critical—but without reinforcement, patients often fall short. Providers can coach patients to:

• Stay active with light but consistent exercise.

   

• Maintain proper nutrition to prevent cachexia.

   

• Use breathing techniques to manage dyspnea.

   

• Stay current with vaccinations to avoid infection-triggered exacerbations.

   

• Recognize their triggers and medications for better self-care.

   

CCM nurses extend the clinical team, offering structured monthly touchpoints to review these strategies, provide education, and resolve issues before they escalate. For practices, this means fewer acute visits, lower preventable admissions, and improved patient satisfaction scores.

---

Management of COPD Exacerbations

Exacerbations are costly inflection points, accelerating disease progression and driving hospital utilization. Providers must focus on both early recognition and prevention.

Warning Signs

Patients should be trained to recognize:

• Worsening dyspnea beyond baseline.

   

• Increased sputum production or changes in color.

   

• Systemic symptoms such as fatigue, fever, or chills.

   

Treatment Options

Depending on severity, management may include:

• Antibiotics for bacterial infections.

   

• Systemic corticosteroids for inflammation.

   

• Hospital-level support when symptoms become severe.

   

Prevention Strategies

Preventing exacerbations yields the greatest ROI. Providers can:

• Optimize inhaler regimens.

   

• Ensure vaccine compliance.

   

• Encourage smoking cessation.

   

• Refer to pulmonary rehab.

   

With RPM in place, providers receive real-time alerts when vitals trend downward, often days before a hospitalization would otherwise occur. Combined with CCM follow-up, this creates a closed-loop system that reduces admissions, prevents readmission penalties, and supports performance in value-based contracts.

---

Conclusion

COPD will always require a multifaceted approach, but today’s best practice extends beyond the clinic. Evidence is clear: outcomes improve most when continuous monitoring, proactive care coordination, and lifestyle reinforcement are layered on top of medications and rehab.

For providers, incorporating Remote Patient Monitoring and Chronic Care Management is not just clinically sound—it’s financially strategic. RPM reduces hospitalizations and readmissions, while CCM ensures engagement and consistent revenue through billable codes. Together, they support improved quality metrics, stronger value-based care performance, and a healthier COPD population.

Key takeaway: COPD management is no longer just about reacting to flare-ups. It’s about building systems that keep patients stable, connected, and engaged—while helping practices reduce costs, capture revenue, and deliver higher-value care.